Eledon Pharmaceuticals Inc (ELDN)
R&D Expenses
$18.23M
Quarterly · Period ending: · USD
ELDN R&D Expenses
Latest reported$18.23Mperiod ending
Latest reported$18.23Mperiod ending
ELDN Quarterly R&D Expenses ($2.70M → $18.23M)
Quarterly R&D Expenses
High-resolution chart · PNG
ELDN r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 18,230,000 | |
| 17,197,000 | |
| 17,491,000 | |
| 14,969,000 | |
| 20,276,000 | |
| 13,531,000 | |
| 17,928,000 | |
| 16,520,000 | |
| 10,106,000 | |
| 7,410,000 | |
| 7,067,000 | |
| 7,931,000 | |
| 7,201,000 | |
| 8,113,000 | |
| 7,250,000 | |
| 7,452,000 | |
| 5,743,000 | |
| 6,635,000 | |
| 6,182,000 | |
| 7,658,000 | |
| 4,242,000 | |
| 5,653,000 | |
| 3,036,000 | |
| 615,000 | |
| 832,000 | |
| 1,648,000 | |
| 1,333,000 | |
| 1,509,000 | |
| 2,297,000 | |
| 2,989,000 | |
| 2,740,000 | |
| 1,651,000 | |
| 1,329,000 | |
| 1,097,000 | |
| 493,000 | |
| 517,000 | |
| 533,000 | |
| 306,000 | |
| 1,036,000 | |
| 6,162,000 | |
| 9,895,000 | |
| 7,931,000 | |
| 7,733,000 | |
| 8,491,000 | |
| 5,855,000 | |
| 10,559,000 | |
| 3,804,000 | |
| 2,825,000 | |
| 4,392,000 | |
| 3,556,000 | |
| 4,349,000 | |
| 2,704,000 |